Sardela de Miranda F, Babcock RL, Mahecha MF, Gukhool PJ, Boligala GP, Garcia AK, Martinez-Marin D, Oliver AG, Hintelmann T, Furr KL, Bose C, Almodovar S, Singh SP, Pruitt K, Melkus MW, Layeequr Rahman R

ImmunoTargets and Therapy 2026, 15:581990

Published Date: 7 April 2026

Review

Guillain-Barré Syndrome: Progress in Diagnosis, Biomarkers, Neuroimaging and Management

Freiha J, Min YG, Osman C, Rajabally YA

ImmunoTargets and Therapy 2026, 15:390161

Published Date: 2 April 2026

Short Report

Circulating miR-148a-3p Correlates with Inadequate Induction Response in Pediatric Hodgkin Lymphoma

Rohde M, Singh VK, Wolfermann A, Burkhardt B, Blattmann C, Steinbach D, Schneider DT, Ebinger M, Maecker-Kolhoff B, Braun M, Kurch L, Mauz-Körholz C, Körholz D

ImmunoTargets and Therapy 2026, 15:577426

Published Date: 1 April 2026

Original Research

Comparative Clinical and Electrophysiological Profiles of Chronic Inflammatory Demyelinating Polyneuropathy in Patients with and without Diabetes Mellitus: An Observational Study

Al Mamun A, Sumi MSN, Hussain ME, Khan AAM, Rassel MA, Kawnayn G, Yusuf MA, Ranjan R, Moureen A, Adhikary D, Alam MB, Mohammad QD, Karim MN

ImmunoTargets and Therapy 2026, 15:592658

Published Date: 26 March 2026

Review

Progress on Potential Therapeutic Targets for Sepsis-Related Cardiac Dysfunction: From Basic Research to Clinical Translation

Gao Y, Dai R, Kong C, Niu Z, Yuan L, Liu X

ImmunoTargets and Therapy 2026, 15:580700

Published Date: 21 March 2026

Original Research

Kasugamycin Inhibits Melanoma Lung Metastasis and CHI3L1-Driven M2-Like Tumor-Associated Macrophage Differentiation

Sadanaga T, Jeong HS, Cortez R, Lee JH, Kamle S, Ma B, Shin SJ, Elias JA, Lee CG

ImmunoTargets and Therapy 2026, 15:563951

Published Date: 19 March 2026

Review

The Role of PD-L1 in Lung Cancer: From Biology to Clinical Application

Lamghari H, Karkouri M

ImmunoTargets and Therapy 2026, 15:591588

Published Date: 19 March 2026

Original Research

NUP85 as a Pan-Cancer Immune Biomarker: Integrated Multi Omics and Functional Analyses Reveal Its Role in Tumor Prognosis

Kong W, Hu Y, Zhang K, Zhu Z, Zou Y, Teng L, Wang X, Zhang J

ImmunoTargets and Therapy 2026, 15:541852

Published Date: 17 March 2026

Original Research

The Conjugation of Antibodies to Heat Shock Protein 70 Activates Immune Responses Against Tumor Cells

Khosravi M, Rajaei A, Mohammadian B, Seyfi Abad Shapouri M

ImmunoTargets and Therapy 2026, 15:565942

Published Date: 16 March 2026

Review

Lymphoproliferation in Inborn Errors of Immunity: Mechanisms, Manifestations and Clinical Management, with a Focus on ALPID

Gualtiero G, Buso H, Coopmans EC, Milito C, Firinu D, Dalm VA, Cinetto F

ImmunoTargets and Therapy 2026, 15:582718

Published Date: 7 March 2026

Review

Recurrent Glioblastoma and the Tumor Immune Landscape: Emerging Immunotherapeutic Strategies

Cao Z, Tong S, Wang Z, Ji C, Zhang C, Dai X, Wu B

ImmunoTargets and Therapy 2026, 15:581012

Published Date: 5 March 2026

Original Research

UVB Upregulates Inflammatory Cytokines in Rosacea Cell Model by Promoting the Expression of TRPVs and TLR2

Xie Y, Hu Y, Huang J, Liu J, Zhang Q

ImmunoTargets and Therapy 2026, 15:571037

Published Date: 4 March 2026

Original Research

Targeting STING Signalling Polarizes Tumor-Associated Neutrophils to Boost Anticancer and Abscopal Antimetastatic Functions

Drzyzga A, Czapla J, Cichoń T, Matuszczak S, Pilny E, Jarosz-Biej M, Ciepła J, Smolarczyk R

ImmunoTargets and Therapy 2026, 15:576457

Published Date: 19 February 2026

Original Research

The Comparative Effectiveness of Enlonstobart and Camrelizumab as Second-Line Recurrent or Metastatic Cervical Cancer Therapies: Matching-Adjusted and Simulated Treatment Comparisons

Gu H, Hu B, Jiang Y

ImmunoTargets and Therapy 2026, 15:572970

Published Date: 19 February 2026

Original Research

The Dual Mechanism of Action of CO-005 Overcomes CD20 Resistance in Diffuse Large B-Cell Lymphoma

Matar S, Skah S, Moltu LE, Åmellem Ø, Hagland HR, Hestdal K, Pettersen RD, Richartz N

ImmunoTargets and Therapy 2026, 15:572396

Published Date: 19 February 2026

Review

Immune Microenvironment of Hair Follicles in Tumor Immunotherapy

Li B, Jiang S, Yang F, Tang M, Lv H, Li L, Chang J

ImmunoTargets and Therapy 2026, 15:554731

Published Date: 16 February 2026

Review

Recent Advances in Vitiligo Treatment

Qiu Y, Su X, Chen J, Jiang S, Tang X, He Y, Liu F

ImmunoTargets and Therapy 2026, 15:577653

Published Date: 11 February 2026

Original Research

Enhancing NK Cell Activity in Colorectal Cancer with an Fc-Optimized Antibody Targeting CD276 (B7-H3)

Stefańczyk SA, Kaiser X, Hagelstein I, Lutz MS, Holzmayer SJ, Zekri L, Märklin M, Jung S

ImmunoTargets and Therapy 2026, 15:533342

Published Date: 10 February 2026

Original Research

A Novel Prognostic Signature Composed of Autophagy and Liver Metastasis in Colorectal Cancer: Comprehensive Analysis of Bulk and Single-Cell Transcriptomic Data

Bai B, Cui Y, Zhong X, Zhu B, Meng Z, Chen L, Di L, Huang L, Wang J, Jin Z, Lu X, Zhou B

ImmunoTargets and Therapy 2026, 15:563779

Published Date: 6 February 2026

Original Research

Enhancing Anti-CTLA-4 Antibody Delivery to the Brain Using Focused Ultrasound and Microbubbles

Afonso Pereira M, Drevenakova V, Liu QE, Grewal S, Morse SV

ImmunoTargets and Therapy 2026, 15:569804

Published Date: 2 February 2026

Review

Emerging Predictive Biomarkers of Immunotherapy Sensitivity in Patients with Non-Small Cell Lung Cancer

Gariazzo E, Colamartini F, Ubaldi M, Santo V, Brunetti L, Tomarelli C, Ognissanti D, Nassar J, Costabile S, Romano L, De Vita E, Scorpiniti I, Macrì M, Porreca R, Currà MF, Cortellini A, Ricciuti B, Metro G

ImmunoTargets and Therapy 2026, 15:567238

Published Date: 2 February 2026

Review

Postural Orthostatic Tachycardia Syndrome, Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Long COVID as Neuroimmune Disorders

Blitshteyn S, Doherty TA, Steinman L

ImmunoTargets and Therapy 2026, 15:581262

Published Date: 2 February 2026

Original Research

Upregulated BLM and RECQL4 in Osteosarcoma: Association with Poor Prognosis, Immune Cell Infiltration, and Inhibitory Effects of Sphingosine Kinase 1 Inhibitor II/Pilaralisib

Chen J, Situ Y, Cai J, Liao W, Jiang D, Huang C, Zheng J, Peng L, Lin H

ImmunoTargets and Therapy 2026, 15:569823

Published Date: 22 January 2026

Original Research

A Retrospective Study on the Clinical Characteristics and Management of Immune-Related Adverse Events in Gynecologic Cancer Patients Treated with Immune Checkpoint Inhibitors

Xia Y, Gao S, Wei Q, Gu W, Li X, Qu H

ImmunoTargets and Therapy 2026, 15:566542

Published Date: 21 January 2026

Original Research

Induction Chemotherapy Followed by Immunotherapy Increases Pathological Complete Response Rate in dMMR/MSI-H Gastric Cancer: A Retrospective Cohort Study

Zeng H, Wu Y, Zhang Z, Liu J, Sun J, Liu X, Gu Y, Tian M, Chen W, Shen Z, Shen K, Xu C, Wang X, Tang Z, Sun Y

ImmunoTargets and Therapy 2026, 15:564230

Published Date: 9 January 2026

Original Research

Macrophage-Derived Transcriptional Signatures Predict Prognosis and Drug Sensitivity in Thyroid Cancer: Integrative Analysis and Experimental Validation of SMYD3

Xu S, Zhang X, Sun J, Qin M, Du H, Luo B

ImmunoTargets and Therapy 2026, 15:565624

Published Date: 9 January 2026

Original Research

Identification of Comprehensive Landscape of Peripheral Immunity and Chemokine-Related Genes in Amyotrophic Lateral Sclerosis

Yang X, Huang S, Wang Y, Yuan J, Yao X

ImmunoTargets and Therapy 2026, 15:566733

Published Date: 9 January 2026

Original Research

The Value of the Preoperative Hematological Inflammatory Markers for Predicting Lymphovascular Invasion in Gastric Cancer

Li C, Wang Y, Liang S, Shi H, Mao X, Wang X, Mo D

ImmunoTargets and Therapy 2026, 15:564201

Published Date: 9 January 2026

Original Research

Effectiveness and Safety of Eculizumab in Highly Active AChR+gMG and Its Therapeutic Response in Different Subtypes of gMG

Ma T, Liu Y, Zhu Y, Gao Y, Wang X, Liang Y, Wang B, Zhu R

ImmunoTargets and Therapy 2026, 15:559497

Published Date: 8 January 2026

Original Research

Risk and Management of Bowel Obstruction in Colorectal Cancer Patients Undergoing Immunotherapy: A Cross-Sectional Multicenter Study

Hong ZG, Xiao B, Zheng M, Yang W, Zhu L, Liang G, Luo Y, Tang J, Mei W, Yu JH, Hou Z, Wu X, Ding P, Jiang W

ImmunoTargets and Therapy 2026, 15:563431

Published Date: 6 January 2026

Original Research

Flow Cytometric Profiling of Peripheral Immune Checkpoints Predicts Prognosis and Reveals PD-1/Treg/IL-10 Crosstalk in B-Cell Lymphoma

Pan B, Li S, Ye R, Zhu J, Tang Y, Li L

ImmunoTargets and Therapy 2025, 14:1555-1568

Published Date: 31 December 2025

Review

TLR9: A Double-Dealing Toll-Like Receptor

Nielsen M, Nishizaki D, Kato S, Kurzrock R

ImmunoTargets and Therapy 2025, 14:1531-1554

Published Date: 30 December 2025

Original Research

Inhibitors of KAT2A Alleviate the Progression of AKI by Alleviating Macrophage Ferritinophagy

Zuo Z, Gao S, Wang J, Liu Z, Lu Z, Wu H, Huang X, Yang C, Chen J, Liu H, Pan Q, Yang L

ImmunoTargets and Therapy 2025, 14:1515-1529

Published Date: 28 December 2025

Review

Precision Medicine in Asthma: The Role of Biomarkers

Quek E, Horn N, Siddiqui S

ImmunoTargets and Therapy 2025, 14:1479-1513

Published Date: 28 December 2025

Review

Immune-Related Adverse Events of Checkpoint Inhibitors and Human Leukocyte Antigen System: A Review

Kośmider K, Kozakiewicz A, Krawczyk P, Kieszko R, Szklener K, Skórzewska M, Wojas-Krawczyk K, Kalinka E, Milanowski J

ImmunoTargets and Therapy 2025, 14:1455-1478

Published Date: 19 December 2025

Original Research

Integrative Spatial Transcriptomics and Experimental Validation Reveal UBC-Mediated EMT Associated with Immune Evasion in Hepatocellular Carcinoma

Li X, Qin X, Shi K, Lu G, Tian G, Chen Y, Yao R

ImmunoTargets and Therapy 2025, 14:1437-1454

Published Date: 19 December 2025

Original Research

Development of a Novel Anti-Siglec-15 Antibody for Tumor Immunotherapy

Liu Q, Li L, Nian S, Sun X, Guo X, Li C, Yang Z, Ye Y, Yuan Q

ImmunoTargets and Therapy 2025, 14:1419-1435

Published Date: 11 December 2025

Case report

Durable Tumor Control with Multi-Organ Immune-Related Adverse Events Following Immune Checkpoint Inhibitor and Sequential Radiotherapy in Locally Advanced NSCLC: A Case Report

Zhai M, Liu X, Li Y, Pi G, Bi J, Han G

ImmunoTargets and Therapy 2025, 14:1411-1417

Published Date: 10 December 2025

Original Research

A Critical Role of DC-SIGN+ Tumor-Associated Macrophages in Colorectal Cancer Immune Evasion and Progression via BCL-3-Mediated PD-L1 Expression

Zhang J, Zhao Y, Wang X, Miao C, Xu W, Wan C, Hu B, Qian F

ImmunoTargets and Therapy 2025, 14:1395-1410

Published Date: 10 December 2025

Review

Neutrophil Extracellular Traps in Sepsis and Sepsis-Related Organ Dysfunction

Yan W, Xu X, Li X, Ma Y, Guo L, Yang J, Jin Z, Zhang J, Li T

ImmunoTargets and Therapy 2025, 14:1373-1393

Published Date: 27 November 2025

Review

The Role of Intestinal Microbiota and Immune System Interactions in Autoimmune Diseases

Yurtseven B, Aydemir E, Ayaz F

ImmunoTargets and Therapy 2025, 14:1347-1372

Published Date: 26 November 2025

Original Research

Deep Learning Classification of Rheumatoid Arthritis in Hand Radiographs Interpretability Insights and Web Application

Cai K, Dou D, Deng G, Zhan Y, Huang H, Feng Z

ImmunoTargets and Therapy 2025, 14:1333-1345

Published Date: 19 November 2025

Original Research

Multi-Dimensional Characterization of Programmed Cell Death Patterns for Prognostic Stratification and Therapeutic Insights in Sepsis

Zhou C, Bai Y

ImmunoTargets and Therapy 2025, 14:1313-1331

Published Date: 15 November 2025